Tag: DPRX

Finance

Why Need to Watch: Dipexium Pharmaceuticals(NASDAQ:DPRX), Yahoo! Inc. (NASDAQ:YHOO), UMH Properties (NYSE:UMH), Consolidated Edison, Inc. (NYSE:ED), The Medicines Company (NASDAQ:MDCO)

On 13 AUG Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) released its earnings data on Wednesday. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.37) by $0.09. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) belongs to Healthcare sector. Its weekly performance is -2.28%. On last trading day company shares ended up $9.00. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) distance from 50-day simple moving average (SMA50) is -5.49%. … Continue reading Why Need to Watch: Dipexium Pharmaceuticals(NASDAQ:DPRX), Yahoo! Inc. (NASDAQ:YHOO), UMH Properties (NYSE:UMH), Consolidated Edison, Inc. (NYSE:ED), The Medicines Company (NASDAQ:MDCO)

Jayne Crisman
Finance

NASDAQ Volatile Stocks: Dipexium Pharmaceuticals (NASDAQ:DPRX), Innodata (NASDAQ:INOD), Huttig Building Products (NASDAQ:HBP), MGC Diagnostics (NASDAQ:MGCD)

Zacks started coverage on shares of Dipexium Pharmaceuticals Inc (NASDAQ:DPRX). The firm issued a hold rating on the stock. Dipexium Pharmaceuticals Inc (NASDAQ:DPRX) stock performance was 4.53% in last session and finished the day at $9.70. Traded volume was 14,020.00million shares in the last session and the average volume of the stock remained 114.51K shares. Dipexium Pharmaceuticals Inc (NASDAQ:DPRX) insider ownership is 47.40%. INNODATA INC. … Continue reading NASDAQ Volatile Stocks: Dipexium Pharmaceuticals (NASDAQ:DPRX), Innodata (NASDAQ:INOD), Huttig Building Products (NASDAQ:HBP), MGC Diagnostics (NASDAQ:MGCD)

Kevin Long
Finance

Biotech New Lows: Akebia Therapeutics (NASDAQ:AKBA), Galmed Pharmaceuticals (NASDAQ:GLMD), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Dipexium Pharmaceuticals (NASDAQ:DPRX)

Akebia Therapeutics Inc. (NASDAQ:AKBA) offered 5.9 million shares in its Thursday IPO at $17 a share, the high end of the stock’s expected price range. Among other therapeutics, the biopharma company is developing a once-daily oral therapy for patients with kidney disease. Akebia Therapeutics, Inc. (NASDAQ:AKBA) stock performance was -0.99% in last session and finished the day at $20.00. Traded volume was 219,904 million shares … Continue reading Biotech New Lows: Akebia Therapeutics (NASDAQ:AKBA), Galmed Pharmaceuticals (NASDAQ:GLMD), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Dipexium Pharmaceuticals (NASDAQ:DPRX)

Kevin Long
Finance

Biotech New Lows: VIVUS (NASDAQ:VVUS), Dipexium Pharmaceuticals (NASDAQ:DPRX), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Galmed Pharmaceuticals (NASDAQ:GLMD)

VIVUS, Inc. (NASDAQ:VVUS) announced that Shari Belafonte is teaming up with the company to educate American adults about seeking medical treatment for chronic weight management when diet and physical activity alone have not been successful. Ms. Belafonte, an actress, model, photographer, writer, singer and daughter of famed musician and actor Harry Belafonte, knows that the impact of being overweight is more than superficial. VIVUS, Inc. … Continue reading Biotech New Lows: VIVUS (NASDAQ:VVUS), Dipexium Pharmaceuticals (NASDAQ:DPRX), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Galmed Pharmaceuticals (NASDAQ:GLMD)

Chris Lewis